SEC Form 4 · accession 0001612551-16-000004
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Munshi
Officer — President and CEO
Period of report
May 11, 2016
Accepted (ET)
May 11, 2016 · 9:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.55 | May 11, 2016 | A | 3,800,000 | A | — | May 11, 2023 | Common Stock | 3,800,000 | 3,800,000 | D |
Explanation of responses
- F1The options vest over four years, with 25% of the shares subject to the option vesting on May 11, 2017, and the remainder of the shares vesting quarterly over the following three years in equal installments (except as otherwise necessary to avoid vesting of a fractional share).